Author

G. Fialkoff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:ChIP-seq· 2 Research Focus:differential expression· 2 Assay:DNA methylation· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1

Frequent Co-Authors

I. Sharkia· 2 shared N. Friedman· 2 shared A. Grinshpun· 1 shared A. Hubert· 1 shared A. Jarjoui· 1 shared A. Quteineh· 1 shared A. Rajan· 1 shared A. Rokach· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

I. Sharkia

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epigenetic liquid biopsies reveal elevated vascular endothelial cell turnover and erythropoiesis in asymptomatic COVID-19 patients

R. Ben Ami, N. Loyfer, E. Cohn, G. Fialkoff, I. Sharkia, N. Bogot, D. Kochan, G. Kalak, A. Jarjoui, C. Chen-Shuali, H. Azulai, H. Barhoum, N. Arish, M. M. Greenberger, D. Velleman, , Y. Dor

This study uses epigenetic liquid biopsies to show that asymptomatic COVID-19 patients have elevated vascular endothelial cell and erythroblast turnover, indicating sub-clinical vascular and erythrocyte damage.

bioRxiv · Jul 28, 2023 · PreprintMicrobiology

Subtyping of Small Cell Lung Cancer using plasma cell-free nucleosomes

G. Fialkoff, N. Takahashi, I. Sharkia, J. Gutin, N. Hermoni, R. Kumar, L. Pongor, S. Nichols, L. Sciuto, C. Graham, P. Desai, M. Nirula, P. Suresh, M. Abel, R. Elmeskini, , A. Thomas

This study uses cfChIP-seq on plasma samples to subtype SCLC based on epigenetic states, linking plasma nucleosome data to tumor transcriptomes and developing a classifier for lineage-defining transcription factors.

bioRxiv · Jun 24, 2022 · PreprintCancer Biology